Canada markets closed

PhaseBio Pharmaceuticals, Inc. (2K4.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.06900.0000 (0.00%)
At close: 10:16AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in USD. All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
Total Revenue
818
10,831
0
Operating Expenses
Research Development
87,696
102,107
72,088
Selling General and Administrative
17,324
16,086
13,088
Total Operating Expenses
105,020
118,193
84,856
Operating Income or Loss
-104,202
-107,362
-84,856
Interest Expense
672
947
1,445
Total Other Income/Expenses Net
2,007
-21,176
-12,501
Income Before Tax
-102,840
-129,471
-98,565
Income Tax Expense
0
1,600
0
Income from Continuing Operations
-102,840
-131,071
-98,565
Net Income
-102,840
-131,071
-98,565
Net Income available to common shareholders
-102,840
-131,071
-98,565
Basic EPS
-
-2.98
-3.39
Diluted EPS
-
-2.98
-3.39
Basic Average Shares
-
43,919
29,056
Diluted Average Shares
-
43,919
29,056